Anika Therapeutics | ANIK - Market Capitalization


Anika Therapeutics reported $215.1M in Market Capitalization this June of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Abbott USD 178.41B 39.46B Mar/2026
Agenus USD 107M 16M Dec/2025
Agios Pharmaceuticals USD 2.01B 423M Mar/2026
Anika Therapeutics USD 139M 3M Dec/2025
Arrowhead Research USD 8.78B 236M Mar/2026
Enanta Pharmaceuticals USD 122M 98M Dec/2024
Halozyme Therapeutics USD 7.66B 257M Mar/2026
Heron Therapeutics USD 238M 7M Dec/2025
Insmed USD 35.3B 1.82B Mar/2026
Integra LifeSciences USD 733M 234M Mar/2026
J&J USD 579.15B 78.91B Mar/2026
Karyopharm Therapeutics USD 1.05B 912M Jun/2026
Ligand Pharmaceuticals USD 3.98B 241M Mar/2026
Merit Medical Systems USD 4.11B 1.11B Mar/2026
Sanofi EUR 100.27B 605.48M Mar/2026
Smith & Nephew USD 3.45B 9.87B Jun/2026
Stryker USD 125.85B 8.57B Mar/2026
Veracyte USD 2.57B 758M Mar/2026
Xencor USD 893M 200M Mar/2026
Zimmer Biomet Holdings USD 17.5B 321M Mar/2026